Health
1 read
New UT Cancer Drug Encourages Immune Response Against Tumors

Want the full story?
Read the complete article at KTSM
AI Summary
Researchers from the University of Texas at Austin and UT MD Anderson have developed an innovative chemotherapy drug that causes cancer cells to behave like viral infections. This unique approach stimulates the immune system to target and attack tumors more effectively, potentially lowering the required doses of traditional chemotherapy. The findings could significantly improve treatment outcomes for cancer patients by enhancing the body's natural defenses against tumors.
cancer health research ut-austin chemotherapy
People & Organizations
UT AustinUT MD Anderson